"il-2" の関連情報検索結果
News
Q&A
Shopping
Auction
Rakuten
amazonA distinct priming phase regulates CD8 T cell immunity by orchestrating paracrine IL-2 signals - ...
A distinct priming phase regulates CD8 T cell immunity by orchestrating paracrine IL-2 signals Science | AAAS
Mural risks going to the wall as IL-2 flop triggers 90% staff reduction, hunt for strategic alter...
Mural risks going to the wall as IL-2 flop triggers 90% staff reduction, hunt for strategic alternatives Fierce Biotech
National Air and Space Museum Completes Restoration of Ilyushin Il-2 Shturmovik - Vintage Aviatio...
National Air and Space Museum Completes Restoration of Ilyushin Il-2 Shturmovik Vintage Aviation News
Breakthrough: New GLP-1/IL-2 Combo Drug Outperforms Standard Therapy by 42% in Alzheimer's Resear...
Breakthrough: New GLP-1/IL-2 Combo Drug Outperforms Standard Therapy by 42% in Alzheimer's Research Stock Titan
An IL-2 mutein increases regulatory T cell suppression of dendritic cells via IL-10 and CTLA-4 to...
An IL-2 mutein increases regulatory T cell suppression of dendritic cells via IL-10 and CTLA-4 to promote T cell anergy ScienceDirect.com
dendritic cell-derived IL-2 dictates CD4 - Nature
Claude on Google Cloud’s Vertex AI: FedRAMP High and IL2 Authorized - Anthropic
Claude on Google Cloud’s Vertex AI: FedRAMP High and IL2 Authorized Anthropic
The Interleukin-2 Market is Set to Reach USD 4 Billion by 2034, Driven by IL-2 Targeting Fusion P...
Abstract 4144964: Low-Dose IL-2 Lowers Arterial Inflammation and Trends Towards Lower MACE in pat...
Abstract 4144964: Low-Dose IL-2 Lowers Arterial Inflammation and Trends Towards Lower MACE in patients with ACS: The results of the IVORY trial and IVORY FINALE study American Heart Association Journals
BCANTT 2024: Rationally Engineered IL2 for Enhanced Treatment of Local and Metastatic Bladder Can...
BCANTT 2024: Rationally Engineered IL2 for Enhanced Treatment of Local and Metastatic Bladder Cancer UroToday
Scientists Identify Key Biomarkers That May Predict Low-Dose IL-2 Treatment Efficacy in People wi...
Scientists Identify Key Biomarkers That May Predict Low-Dose IL-2 Treatment Efficacy in People with Systemic Lupus Erythematosus Lupus Foundation of America
IL-2 based cancer immunotherapies: an evolving paradigm - Frontiers
IL-2 based cancer immunotherapies: an evolving paradigm Frontiers
Coordinating interleukin-2 encoding circRNA with immunomodulatory lipid nanoparticles to potentia...
Coordinating interleukin-2 encoding circRNA with immunomodulatory lipid nanoparticles to potentiate cancer immunotherapy Science | AAAS
Harnessing IL-2 for immunotherapy against cancer and chronic infection: a historical perspective ...
Novel [18F]FPG-interleukin-2 conjugate for monitoring immune checkpoint therapy with positron emi...
Novel [18F]FPG-interleukin-2 conjugate for monitoring immune checkpoint therapy with positron emission tomography ScienceDirect.com
A tetraspecific engager armed with a non-alpha IL-2 variant harnesses natural killer cells agains...
A tetraspecific engager armed with a non-alpha IL-2 variant harnesses natural killer cells against B cell non-Hodgkin lymphoma Science | AAAS
Spatial microniches of IL-2 combine with IL-10 to drive lung migratory T - Nature
Spatial microniches of IL-2 combine with IL-10 to drive lung migratory T Nature
Targeting systemic IL-2 to BCMA CAR-T cells - Nature
T cells during infection requires MRTF/SRF-dependent gene expression and cytoskeletal dynamics - ...
T cells during infection requires MRTF/SRF-dependent gene expression and cytoskeletal dynamics Nature
Tebentafusp, a T cell engager, promotes macrophage reprogramming and in combination with IL-2 ove...
IL-2/anti-IL-2 antibody complexes augment immune responses to therapeutic cancer vaccines - PNAS
IL-2/anti-IL-2 antibody complexes augment immune responses to therapeutic cancer vaccines PNAS
The regulatory T cell-selective interleukin-2 receptor agonist rezpegaldesleukin in the treatment...
Human serum albumin promotes interactions between HSA-IL-2 fusion protein and CD122 for enhancing...
Human serum albumin promotes interactions between HSA-IL-2 fusion protein and CD122 for enhancing immunotherapy ScienceDirect.com
Low-dose IL-2 promising in bullous pemphigoid treatment - Healio
Low-dose IL-2 promising in bullous pemphigoid treatment Healio
WW2 Flight Sim Il-2 Sturmovik Announces Final Expansion Before New Korea Game - DualShockers
WW2 Flight Sim Il-2 Sturmovik Announces Final Expansion Before New Korea Game DualShockers
Role of soluble interleukin-2 receptor (sIL-2R) as a predictor for severe dengue infection - Nature
Role of soluble interleukin-2 receptor (sIL-2R) as a predictor for severe dengue infection Nature
IL-2–inducible T cell kinase deficiency sustains chimeric antigen receptor T cell therapy against...
Coya touts partnership potential as IL-2 prospect comes through small Alzheimer's study - Fierce ...
Coya touts partnership potential as IL-2 prospect comes through small Alzheimer's study Fierce Biotech
Neoleukin-2/15-armored CAR-NK cells sustain superior therapeutic efficacy in solid tumors via c-M...
Tyrosine phosphorylation of both STAT5A and STAT5B is necessary for maximal IL-2 signaling and T ...
AWT020: a novel fusion protein harnessing PD-1 blockade and selective IL-2 Cis-activation for enh...
Based on the immune system: the role of the IL-2 family in pancreatic disease - Frontiers
Based on the immune system: the role of the IL-2 family in pancreatic disease Frontiers
Oncotelic Therapeutics Announces Successful Completion of Phase 1 Trial of OT-101 and IL-2, Highl...
IL-2 Sturmovik Flying Circus Vol. IV Released - FSElite
IL-2 Signaling Axis Defects: How Many Faces? - Frontiers
IL-2 Receptor-Targeted Therapy Approved for Relapsed/Refractory CTCL - MedPage Today
IL-2 Receptor-Targeted Therapy Approved for Relapsed/Refractory CTCL MedPage Today
The IL-2 Defect in Systemic Lupus Erythematosus Disease Has an Expansive Effect on Host Immunity ...
The IL-2 Defect in Systemic Lupus Erythematosus Disease Has an Expansive Effect on Host Immunity Wiley Online Library
Synthekine Announces Presentation of New Translational Data from Phase 1a/1b Clinical Trial of α/...
A Comprehensive Review of Low-Dose Interleukin-2 (IL-2) Therapy for Systemic Lupus Erythematosus:...
Engineered IL-2 molecule shows promise in treating autoimmune disease - McGill University
Engineered IL-2 molecule shows promise in treating autoimmune disease McGill University
Development at Rockford’s US-20 and IL-2 interchange could soon bring 37,000 jobs - MyStateline
Development at Rockford’s US-20 and IL-2 interchange could soon bring 37,000 jobs MyStateline
Aulos Bioscience to Present Promising Phase 2 Data for Novel IL-2 Therapeutic AU-007 in Melanoma ...
Novel design of potent anti-tumour activity of IL-2 prodrug by FAPα-mediated activation - Science...
Novel design of potent anti-tumour activity of IL-2 prodrug by FAPα-mediated activation ScienceDirect.com
(PDF) Low-dose IL-2 in the treatment of immune-related diseases - ResearchGate
(PDF) Low-dose IL-2 in the treatment of immune-related diseases ResearchGate
IL-2 Korea Announcement - FSElite
IL-2 Korea Announcement FSElite
IL-2-free tumor-infiltrating lymphocyte therapy with PD-1 blockade demonstrates potent efficacy i...
De novo design of mini-binder proteins against IL-2 receptor β chain - ScienceDirect.com
De novo design of mini-binder proteins against IL-2 receptor β chain ScienceDirect.com
The Structure of Interleukin-2 Complexed with Its Alpha Receptor - Science | AAAS
The Structure of Interleukin-2 Complexed with Its Alpha Receptor Science | AAAS
Combined analysis of host IFN-γ, IL-2 and IP-10 as potential LTBI biomarkers in ESAT-6/CFP-10 sti...
(PDF) Alteration in the IL-2 signal peptide affects secretion of proteinsin vitro andin vivo - Re...
(PDF) Alteration in the IL-2 signal peptide affects secretion of proteinsin vitro andin vivo ResearchGate
Innovent braves bruising cytokine space, linking fusion protein to tumor responses in small study...
Innovent braves bruising cytokine space, linking fusion protein to tumor responses in small study Fierce Biotech
Low Dose Interleukin-2 Ameliorates Sjögren’s Syndrome in a Murine Model - Frontiers
Low Dose Interleukin-2 Ameliorates Sjögren’s Syndrome in a Murine Model Frontiers
FIGURE 3. IL-2 controls the frequency of T reg cells in vivo. A, Flow... - ResearchGate
FIGURE 3. IL-2 controls the frequency of T reg cells in vivo. A, Flow... ResearchGate
Figure 3. IL-2 modification for cellular targeting and prolonged... - ResearchGate
Figure 3. IL-2 modification for cellular targeting and prolonged... ResearchGate
IFNγ-secreting T cells that highly express IL-2 potently inhibit the growth of intracellular M. t...
IL‐2 amplifies quantitative TCR signalling inputs to drive Th1 and Th2 differentiation - Al‐Aghba...
IL‐2 amplifies quantitative TCR signalling inputs to drive Th1 and Th2 differentiation - Al‐Aghbar - 2024 - Immunology Wiley Online Library
Fig. 4. IL-2-induced T cell proliferation in the presence of high-dose... - ResearchGate
Fig. 4. IL-2-induced T cell proliferation in the presence of high-dose... ResearchGate
FIGURE 3. IL-2 controls the frequency of T reg cells in vivo. A, Flow... - ResearchGate
FIGURE 3. IL-2 controls the frequency of T reg cells in vivo. A, Flow... ResearchGate
Fig. 1. Interleukin-2 takes center stage. The different functional... - ResearchGate
Fig. 1. Interleukin-2 takes center stage. The different functional... ResearchGate
Korea IL-2 Series Brings The Military Flight Sim To PC VR Next Year - UploadVR
Korea IL-2 Series Brings The Military Flight Sim To PC VR Next Year UploadVR
Patient Overcomes Advanced Melanoma With Rare IL-2 Treatment - University of Cincinnati
Patient Overcomes Advanced Melanoma With Rare IL-2 Treatment University of Cincinnati
Fig. 3. Validation of IL-2 activation in gluten-induced recall... - ResearchGate
Fig. 3. Validation of IL-2 activation in gluten-induced recall... ResearchGate
GRIT and Quangang announce IL-2 T-cell therapy partnership - Pharmaceutical Technology
GRIT and Quangang announce IL-2 T-cell therapy partnership Pharmaceutical Technology
Cleanup on IL-2 - Science | AAAS
Cleanup on IL-2 Science | AAAS
FIGURE 4. IL-2 mutein binds preferentially to Treg cells releasing Treg... - ResearchGate
FIGURE 4. IL-2 mutein binds preferentially to Treg cells releasing Treg... ResearchGate
IL-2/anti-IL-2 antibody complexes augment immune responses to therapeutic cancer vaccines - PNAS
IL-2/anti-IL-2 antibody complexes augment immune responses to therapeutic cancer vaccines PNAS
Fig. 1. IL-2 receptor structure and signaling. IL-2 binds to the IL-2Rα... - ResearchGate
Fig. 1. IL-2 receptor structure and signaling. IL-2 binds to the IL-2Rα... ResearchGate
Nanoparticles loaded with IL-2 and TGF-β promote transplantation tolerance to alloantigen - Front...
Nanoparticles loaded with IL-2 and TGF-β promote transplantation tolerance to alloantigen Frontiers
The Blockade of Interleukin-2 During the Acute Phase of Trypanosoma cruzi Infection Reveals Its D...
Figure 1. Interleukin-2 (IL-2) production, epitopes, and receptors.... - ResearchGate
Figure 1. Interleukin-2 (IL-2) production, epitopes, and receptors.... ResearchGate
FIG. 4. Increased IL-2 production and T-cell proliferation in... - ResearchGate
FIG. 4. Increased IL-2 production and T-cell proliferation in... ResearchGate
Synthekine nabs $100M to boost IL-2 programs after rivals hit setbacks - Endpoints News
Synthekine nabs $100M to boost IL-2 programs after rivals hit setbacks Endpoints News
Novel IL-2 Agent Shows Promise in Advanced Solid Tumors - MedPage Today
Novel IL-2 Agent Shows Promise in Advanced Solid Tumors MedPage Today
Dual role of IL-2 signaling mediated by different IL-2 receptor... - ResearchGate
Dual role of IL-2 signaling mediated by different IL-2 receptor... ResearchGate
ESMO Virtual Plenary: Ph I trial of PD-1/IL-2 BsAb in pts with advanced cancer - ESMO
ESMO Virtual Plenary: Ph I trial of PD-1/IL-2 BsAb in pts with advanced cancer ESMO
IL-2 Program Profits With Bonum's Drs. John Mulligan And Neela Patel - Life Science Leader
IL-2 Program Profits With Bonum's Drs. John Mulligan And Neela Patel Life Science Leader
Fig. 2. Increases in Tregs after single dose in vivo IL-2 treatments.... - ResearchGate
Fig. 2. Increases in Tregs after single dose in vivo IL-2 treatments.... ResearchGate
Figure 4. IL-2-REH selectively promotes signaling in Tregs with reduced... - ResearchGate
Figure 4. IL-2-REH selectively promotes signaling in Tregs with reduced... ResearchGate
FIGURE 5. IL-2 secretion is required for enhanced STAT5 activation and... - ResearchGate
FIGURE 5. IL-2 secretion is required for enhanced STAT5 activation and... ResearchGate
Figure 2. IL-2 dose-dependent receptor response. In steady state low to... - ResearchGate
Figure 2. IL-2 dose-dependent receptor response. In steady state low to... ResearchGate
IL-2 Series To Produce New Game Based On The Korean War - Bleeding Cool News
IL-2 Series To Produce New Game Based On The Korean War Bleeding Cool News
Figure 1: IL-2 signals program CD8+ T cells for secondary population... - ResearchGate
Figure 1: IL-2 signals program CD8+ T cells for secondary population... ResearchGate
Figure 4. In vitro NK proliferation (A) IL-2 consumption by T cells was... - ResearchGate
Figure 4. In vitro NK proliferation (A) IL-2 consumption by T cells was... ResearchGate
Soluble Interleukin-2 Receptor Level as a Marker of Hemophagocytic Lymphohistiocytosis in Childre...
Interleukin-2 Mediated Expansion of T-Regulatory Cells as an Ischemic Stroke Therapy - American H...
Interleukin-2 Mediated Expansion of T-Regulatory Cells as an Ischemic Stroke Therapy American Heart Association Journals
Signaling through IL-2 receptor (IL-2R) pathway. IL-2 exerts its... - ResearchGate
Signaling through IL-2 receptor (IL-2R) pathway. IL-2 exerts its... ResearchGate
Pros and cons of high dose (HD) interleukin-2 (IL-2) therapy for... - ResearchGate
Pros and cons of high dose (HD) interleukin-2 (IL-2) therapy for... ResearchGate
A phase 1 proof-of-concept study evaluating safety, tolerability, and biological marker responses...
Novel approaches for IL-2 based cancer immunotherapy. Various... - ResearchGate
Novel approaches for IL-2 based cancer immunotherapy. Various... ResearchGate
Adjuvantation of a SARS-CoV-2 mRNA vaccine with controlled tissue-specific expression of an mRNA ...
Adjuvantation of a SARS-CoV-2 mRNA vaccine with controlled tissue-specific expression of an mRNA encoding IL-12p70 Science | AAAS
Effect of Low-dose IL-2 on T cell activation and proliferation in the... - ResearchGate
Effect of Low-dose IL-2 on T cell activation and proliferation in the... ResearchGate
PGE2 inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial function - Nature
PGE2 inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial function Nature
A humanized IL-2 mutein expands Tregs and prolongs transplant survival in preclinical models - JC...
A humanized IL-2 mutein expands Tregs and prolongs transplant survival in preclinical models JCI.org
Korea. IL-2 Series - Official Reveal Trailer - IGN
IL-6 mediates the IL-2 responsiveness of Tfh cells. In the presence of... - ResearchGate
IL-6 mediates the IL-2 responsiveness of Tfh cells. In the presence of... ResearchGate
Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes - Sci...
Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes Science | AAAS
IL-2- and Blimp-1-Dependent Effector CD8 + T Cell Differentiation - ResearchGate
IL-2- and Blimp-1-Dependent Effector CD8 + T Cell Differentiation ResearchGate
Overcoming toxicities: are IL-2 smart cytokines the next big thing? - Labiotech.eu
Overcoming toxicities: are IL-2 smart cytokines the next big thing? Labiotech.eu
Signaling network of the IL-2 cytokine family. Receptors of IL-2,... - ResearchGate
Signaling network of the IL-2 cytokine family. Receptors of IL-2,... ResearchGate
PD-1 combination therapy with IL-2 modifies CD8+ T cell exhaustion program - Nature
PD-1 combination therapy with IL-2 modifies CD8+ T cell exhaustion program Nature